-

Deca Dental Group Announces Strategic Investment From Blackstone Tactical Opportunities

DALLAS--(BUSINESS WIRE)--DECA Dental Group (“DECA” or the “Company”), a leading dental services organization, today announced a strategic investment from funds managed by Blackstone Tactical Opportunities (NYSE: BX; “Blackstone”).

This partnership will help fuel DECA’s continued expansion, giving more dentists a platform to provide high quality, patient-centric, and convenient care to communities across the country. Founded in Dallas in 2008, DECA has nearly 100 affiliated dental practices with a network of offices in Texas, Florida and Washington.

Dr. Sulman Ahmed, Founder and Chief Executive Officer of DECA Dental Group, will continue to run the company and chair the Board of Directors. Dr. Ahmed said: “We are thrilled to partner with Blackstone for DECA’s next phase of growth. We founded the company to transform dentistry, offering clinicians the systems and support they need to focus on what really matters: providing quality patient care. Blackstone’s capital and resources will allow us to further expand this proven model nationwide.”

Todd Hirsch, a Senior Managing Director at Blackstone, said: “Dr. Ahmed and his team have created a first-rate experience for both clinicians and patients. We believe DECA has a differentiated platform because the Company was founded and is led by outstanding dentists. Their success expanding into new markets organically, through de novo offices, and through affiliations is a testament to the power of their patient-first model. We are excited to support DECA’s expansion across the U.S.”

Terms of the transaction were not disclosed. Houlihan Lokey acted as the Company’s financial advisor. Weil, Gotshal & Manges LLP acted as Blackstone’s legal advisor.

About DECA Dental Group

Founded in Dallas, DECA Dental Group has been delivering high quality, affordable dental care to patients since 2008. DECA has nearly 100 affiliated dental practices with a network of offices in Texas, Florida and Washington. DECA’s culture is founded on a patient-centric model. The company is guided by its vision to be the premier provider of dental services under one roof while being the first choice for dentists and staff seeking a partner for growth, innovation and learning. To learn more, please visit https://decadental.com.

About Blackstone

Blackstone is the world’s largest alternative asset manager. We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. We do this by using extraordinary people and flexible capital to help companies solve problems. Our $684 billion in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, life sciences, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. Further information is available at www.blackstone.com. Follow Blackstone on Twitter @Blackstone.

Contacts

Matt Anderson
(518) 248-7310
matthew.anderson@blackstone.com

Tom Clements
(646) 482-6088
thomas.clements@blackstone.com

Blackstone

NYSE:BX

Release Versions

Contacts

Matt Anderson
(518) 248-7310
matthew.anderson@blackstone.com

Tom Clements
(646) 482-6088
thomas.clements@blackstone.com

More News From Blackstone

Blackstone Real Estate Debt Strategies Launches Homebuilder Lending Platform

NEW YORK--(BUSINESS WIRE)--Blackstone (NYSE: BX) today announced that Blackstone Real Estate Debt Strategies (“BREDS”) has launched a lending platform that will provide much needed capital and flexibility to homebuilders, and expects to enable the construction of over 50,000 for-sale homes across the United States annually. This lending platform is supported by BREDS portfolio company, Brio Homebuilder Solutions, as well as partnerships with third parties. This commitment comes at a time when t...

Blackstone Life Sciences Invests $250 Million in Anagram Therapeutics to Advance Novel and Patient-Friendly Oral Enzyme Replacement Therapy for Pancreatic Insufficiency

NEW YORK & NATICK, Mass.--(BUSINESS WIRE)--Blackstone Life Sciences (“BXLS”) today announced a $250 million investment in Anagram Therapeutics (“Anagram”), a clinical-stage private biopharmaceutical company dedicated to improving the lives of people living with exocrine pancreatic insufficiency due to cystic fibrosis (“CF”), pancreatic cancer and related disorders. The investment will help fund the further development, approval and launch of Anagram’s ANG003, a novel orally delivered recombinan...

Anthropic Partners with Blackstone, Hellman & Friedman, and Goldman Sachs to Launch Enterprise AI Services Firm

SAN FRANCISCO--(BUSINESS WIRE)--Anthropic, Blackstone, Hellman & Friedman, and Goldman Sachs today announced the formation of a new AI-native enterprise services firm that will work with companies to rapidly bring Claude into their core business operations. The new firm is a standalone entity with Anthropic engineering and partnership resources embedded directly within its team. Alongside the founding partners, the new company is backed by a consortium of leading alternative asset managers...
Back to Newsroom